Nandrolone Phenylpropionate and the Mind: Mood, Aggression and Sleep
Discussions of anabolic steroids usually focus on muscle, liver enzymes and cholesterol. The effects on mood, sleep and behavior get less attention, even though they are often what family members notice first. Our editorial team reviewed the research on nandrolone and related compounds to describe honestly what is known, what is uncertain and when to seek help.
What nandrolone phenylpropionate is
Nandrolone is a synthetic derivative of testosterone, differing by the absence of a methyl group at the 19th carbon position, which is why its chemical family is called 19-nortestosterones. Phenylpropionate is the ester attached to the molecule; it determines how slowly the drug is released from an intramuscular injection.
Nandrolone decanoate has an approved medical history in the United States for certain anemias, and nandrolone esters have been studied in conditions such as HIV-associated muscle wasting. Nandrolone is a Schedule III controlled substance, and non-prescribed use is unlawful.
Pharmacologically, nandrolone binds the androgen receptor. Unlike testosterone, it is a poor substrate for 5-alpha reductase in many tissues, and its metabolites interact with the progesterone receptor, a feature often cited when discussing its distinct side-effect profile.
It is also one of the most frequently detected substances in anti-doping testing, partly because its metabolites can be identified for a long time after use. Nandrolone and its metabolites are prohibited at all times under the WADA Prohibited List.
How androgens interact with the brain
Androgen receptors are present throughout the brain, including the amygdala, hypothalamus and hippocampus, regions involved in emotion, stress response and memory. Supraphysiologic hormone exposure therefore has a plausible biological route to affect behavior.
Animal research on nandrolone has reported changes in aggression-related behavior and in neurotransmitter systems, including serotonin and dopamine signaling. Animal findings cannot be translated directly to humans, but they establish that the effects are not purely psychological.
Human studies add a complication: expectation. People who use steroids know they are using them, which can shape perceived changes in confidence or aggression. Only blinded trials can separate drug effects from expectation.
Because nandrolone metabolites also act at the progesterone receptor, some clinicians suggest this may contribute to effects on mood and libido that differ from testosterone. This remains a hypothesis rather than an established mechanism in humans.
What human studies and case reports show
Blinded studies with testosterone give the clearest evidence. Pope, Kouri and Hudson (2000) administered testosterone or placebo to healthy men in a crossover design and found that manic symptoms and aggressive responses increased in a minority of participants, with marked individual variation. Most men showed little change; a few reacted strongly.
Observational research in users paints a broader picture. Kanayama, Hudson and Pope (2008) reviewed psychiatric consequences and described irritability, hypomanic episodes during use and depressive symptoms after discontinuation, sometimes severe.
Dependence is a documented phenomenon. A proportion of long-term users meet criteria for dependence, continuing use despite harm and experiencing withdrawal symptoms including low mood, fatigue and loss of libido when stopping.
Specific data on nandrolone phenylpropionate in humans are sparse. Most psychiatric evidence concerns anabolic-androgenic steroids as a class, and it is reasonable to assume class effects while acknowledging that compound-specific differences are not well characterized.
Sleep, libido and quality of life
Sleep complaints are common in reports from users: difficulty falling asleep, night sweats, and waking during the night. Several contributing factors are plausible, including higher metabolic rate, elevated blood pressure, anxiety and in some cases sleep-disordered breathing related to rapid weight gain.
Androgen use has been associated with worsening obstructive sleep apnea in some patients, and untreated apnea itself causes daytime fatigue, irritability and mood problems. This creates a loop in which poor sleep amplifies emotional symptoms.
| Reported symptom | Possible contributors | What helps assessment |
|---|---|---|
| Irritability, short temper | Hormonal effects, sleep loss, expectation | Feedback from family; mood tracking |
| Insomnia, night sweats | Metabolic rate, blood pressure, anxiety | Sleep diary, blood pressure log |
| Low mood after stopping | Suppressed natural testosterone, withdrawal | Hormone panel, clinical evaluation |
| Low libido | Axis suppression, progestogenic effects, prolactin | Testosterone, estradiol, prolactin testing |
| Loud snoring, daytime sleepiness | Possible sleep apnea | Sleep study referral |
Nandrolone is often associated anecdotally with reduced libido or erectile difficulties despite high muscle-building effect, a pattern sometimes linked to its progestogenic activity and to suppression of natural testosterone production. Controlled human data are limited.
Partners and family members frequently notice behavioral changes before the user does. Their observations are clinically useful information, not an insult.
Stopping, recovery and when to get help
The period after stopping is when psychiatric risk appears highest. Natural testosterone production is suppressed, and recovery can take weeks to many months. Rahnema et al. (2014) described anabolic steroid-induced hypogonadism and noted that some men develop prolonged symptoms.
During that window, low mood, anhedonia, fatigue and loss of motivation are common. Because these overlap with major depression, and because suicidal thinking has been reported in this context, symptoms should be taken seriously rather than waited out alone.
- Persistent low mood or loss of interest lasting more than two weeks warrants medical evaluation.
- Any thoughts of self-harm are an urgent reason to seek help; in the US, call or text 988 for the Suicide and Crisis Lifeline.
- Escalating aggression, especially toward others, requires professional support.
- Inability to stop despite wanting to stop is a sign of dependence that treatment can address.
Treatment is available and is a medical matter, not a moral one. Endocrinologists and urologists manage hormonal recovery, while psychiatrists and psychologists address mood, sleep and dependence. Disclosing use honestly allows both sides of the problem to be treated.
Prevention is simpler: realistic goals, periodized training, adequate sleep and recovery, and professional guidance reduce the perceived need for pharmacology in the first place.
Conclusions of the editorial team
Psychiatric effects are a real part of the anabolic steroid risk profile, with irritability and mood instability during use and depressive symptoms after stopping.
Responses vary widely between individuals; blinded research shows that a minority of men react strongly while most show modest changes.
Sleep problems, low libido and possible sleep apnea often interact with mood symptoms and should be assessed medically rather than ignored.
Related reading from our team: recovery of the hormonal axis after steroid use, how to interpret a prolactin test, and sleep strategies for athletes under heavy training load.
References
- Pope HG Jr, Kouri EM, Hudson JI. Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry. 2000;57(2):133–140.
- Kanayama G, Hudson JI, Pope HG Jr. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend. 2008;98(1–2):1–12.
- Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341–375.
- Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction. 2009;104(12):1966–1978.
- Rahnema CD, Lipshultz LI, Crosnoe LE, Kovac JR, Kim ED. Anabolic steroid-induced hypogonadism: diagnosis and treatment. Fertil Steril. 2014;101(5):1271–1279.
- Piacentino D, Kotzalidis GD, Del Casale A, et al. Anabolic-androgenic steroid use and psychopathology in athletes: a systematic review. Curr Neuropharmacol. 2015;13(1):101–121.
